Literature DB >> 8880241

A randomized cross-over comparison of the hemodynamic response to intermittent hemodialysis and continuous hemofiltration in ICU patients with acute renal failure.

B Misset1, J F Timsit, S Chevret, B Renaud, F Tamion, J Carlet.   

Abstract

OBJECTIVE: To compare the hemodynamic response of ICU patients with acute renal failure of a 24-h continuous arteriovenous hemofiltration (CAVH) and that of patients with a 4-h intermittent hemodialysis (HD).
DESIGN: Cross-over randomized clinical trial. The two periods to be compared were a 24-h CAVH and the 24-h encompassing a 4-h HD. These two periods were separated by a 24-h wash-out period.
SETTING: Ten bed medicosurgical ICU of a tertiary care center in Paris, France. PATIENTS: Inclusion criterion was the requirement of replacement therapy for acute renal failure in patients already submitted to mechanical ventilation.
INTERVENTIONS: CAVH was performed with Ringers' lactate used for restitution and infused before the hemofilter. The ultrafiltrate output was maintained at around 15 ml/min. HD was performed with a bicarbonate-buffered dialysate. MEAN OUTCOME MEASURES: Mean arterial pressure (MAP), use of adrenergic drugs, and change in body weight during each period.
RESULTS: Twenty-seven consecutive patients were included, 15 CAVH-HD and 12HD-CAVH. CAVH and HD allowed the same metabolic efficacy. No hemodynamic parameter (MAP, amount of adrenergic drugs, change in body weight) differed between the two methods.
CONCLUSIONS: CAVH is equivalent to HD in terms of MAP and the use of vasopressive drugs and fluids. Establishing the superiority of CAVH would require carefully controlled studies assessing either outcome or changes in tissue oxygenation.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8880241     DOI: 10.1007/bf01709515

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  11 in total

Review 1.  European Society of Intensive Care Medicine. Expert panel: the use of the pulmonary artery catheter.

Authors: 
Journal:  Intensive Care Med       Date:  1991       Impact factor: 17.440

2.  Septic shock and multiple organ failure: treatment with haemofiltration?

Authors:  A B Groeneveld
Journal:  Intensive Care Med       Date:  1990       Impact factor: 17.440

Review 3.  Lactate metabolism.

Authors:  J A Kruse; R W Carlson
Journal:  Crit Care Clin       Date:  1987-10       Impact factor: 3.598

4.  The two-period cross-over clinical trial.

Authors:  M Hills; P Armitage
Journal:  Br J Clin Pharmacol       Date:  1979-07       Impact factor: 4.335

5.  Management of anuric intensive-care patients with arteriovenous hemofiltration.

Authors:  P Kramer; G Kaufhold; H J Gröne; W Wigger; J Rieger; D Matthaei; T Stokke; H Burchardi; F Scheler
Journal:  Int J Artif Organs       Date:  1980-07       Impact factor: 1.595

6.  Sympathetic and hemodynamic response to volume removal during different forms of renal replacement therapy.

Authors:  C A Baldamus; W Ernst; U Frei; K M Koch
Journal:  Nephron       Date:  1982       Impact factor: 2.847

7.  Effect of continuous venovenous hemofiltration with dialysis on hormone and catecholamine clearance in critically ill patients with acute renal failure.

Authors:  R Bellomo; B McGrath; N Boyce
Journal:  Crit Care Med       Date:  1994-05       Impact factor: 7.598

8.  Improved cardiovascular stability during continuous modes of renal replacement therapy in critically ill patients with acute hepatic and renal failure.

Authors:  A Davenport; E J Will; A M Davidson
Journal:  Crit Care Med       Date:  1993-03       Impact factor: 7.598

9.  Gastric intramucosal pH as a therapeutic index of tissue oxygenation in critically ill patients.

Authors:  G Gutierrez; F Palizas; G Doglio; N Wainsztein; A Gallesio; J Pacin; A Dubin; E Schiavi; M Jorge; J Pusajo
Journal:  Lancet       Date:  1992-01-25       Impact factor: 79.321

10.  Pulmonary artery catheter infections. A prospective study.

Authors:  M L Myers; T W Austin; W J Sibbald
Journal:  Ann Surg       Date:  1985-02       Impact factor: 12.969

View more
  15 in total

1.  Continous renal replacement therapy and intermittent hemodialysis in acute kidney injury: equivalent or complementary?

Authors:  R T Noel Gibney
Journal:  J Thorac Dis       Date:  2016-09       Impact factor: 2.895

2.  Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016.

Authors:  Andrew Rhodes; Laura E Evans; Waleed Alhazzani; Mitchell M Levy; Massimo Antonelli; Ricard Ferrer; Anand Kumar; Jonathan E Sevransky; Charles L Sprung; Mark E Nunnally; Bram Rochwerg; Gordon D Rubenfeld; Derek C Angus; Djillali Annane; Richard J Beale; Geoffrey J Bellinghan; Gordon R Bernard; Jean-Daniel Chiche; Craig Coopersmith; Daniel P De Backer; Craig J French; Seitaro Fujishima; Herwig Gerlach; Jorge Luis Hidalgo; Steven M Hollenberg; Alan E Jones; Dilip R Karnad; Ruth M Kleinpell; Younsuk Koh; Thiago Costa Lisboa; Flavia R Machado; John J Marini; John C Marshall; John E Mazuski; Lauralyn A McIntyre; Anthony S McLean; Sangeeta Mehta; Rui P Moreno; John Myburgh; Paolo Navalesi; Osamu Nishida; Tiffany M Osborn; Anders Perner; Colleen M Plunkett; Marco Ranieri; Christa A Schorr; Maureen A Seckel; Christopher W Seymour; Lisa Shieh; Khalid A Shukri; Steven Q Simpson; Mervyn Singer; B Taylor Thompson; Sean R Townsend; Thomas Van der Poll; Jean-Louis Vincent; W Joost Wiersinga; Janice L Zimmerman; R Phillip Dellinger
Journal:  Intensive Care Med       Date:  2017-01-18       Impact factor: 17.440

3.  The Japanese Clinical Practice Guideline for acute kidney injury 2016.

Authors:  Kent Doi; Osamu Nishida; Takashi Shigematsu; Tomohito Sadahiro; Noritomo Itami; Kunitoshi Iseki; Yukio Yuzawa; Hirokazu Okada; Daisuke Koya; Hideyasu Kiyomoto; Yugo Shibagaki; Kenichi Matsuda; Akihiko Kato; Terumasa Hayashi; Tomonari Ogawa; Tatsuo Tsukamoto; Eisei Noiri; Shigeo Negi; Koichi Kamei; Hirotsugu Kitayama; Naoki Kashihara; Toshiki Moriyama; Yoshio Terada
Journal:  J Intensive Care       Date:  2018-08-13

4.  [Prevention, diagnosis, treatment, and follow-up care of sepsis. First revision of the S2k Guidelines of the German Sepsis Society (DSG) and the German Interdisciplinary Association for Intensive and Emergency Care Medicine (DIVI)].

Authors:  K Reinhart; F M Brunkhorst; H-G Bone; J Bardutzky; C-E Dempfle; H Forst; P Gastmeier; H Gerlach; M Gründling; S John; W Kern; G Kreymann; W Krüger; P Kujath; G Marggraf; J Martin; K Mayer; A Meier-Hellmann; M Oppert; C Putensen; M Quintel; M Ragaller; R Rossaint; H Seifert; C Spies; F Stüber; N Weiler; A Weimann; K Werdan; T Welte
Journal:  Anaesthesist       Date:  2010-04       Impact factor: 1.041

Review 5.  The Japanese clinical practice guideline for acute kidney injury 2016.

Authors:  Kent Doi; Osamu Nishida; Takashi Shigematsu; Tomohito Sadahiro; Noritomo Itami; Kunitoshi Iseki; Yukio Yuzawa; Hirokazu Okada; Daisuke Koya; Hideyasu Kiyomoto; Yugo Shibagaki; Kenichi Matsuda; Akihiko Kato; Terumasa Hayashi; Tomonari Ogawa; Tatsuo Tsukamoto; Eisei Noiri; Shigeo Negi; Koichi Kamei; Hirotsugu Kitayama; Naoki Kashihara; Toshiki Moriyama; Yoshio Terada
Journal:  Clin Exp Nephrol       Date:  2018-10       Impact factor: 2.801

6.  Prevention, diagnosis, therapy and follow-up care of sepsis: 1st revision of S-2k guidelines of the German Sepsis Society (Deutsche Sepsis-Gesellschaft e.V. (DSG)) and the German Interdisciplinary Association of Intensive Care and Emergency Medicine (Deutsche Interdisziplinäre Vereinigung für Intensiv- und Notfallmedizin (DIVI)).

Authors:  K Reinhart; F M Brunkhorst; H-G Bone; J Bardutzky; C-E Dempfle; H Forst; P Gastmeier; H Gerlach; M Gründling; S John; W Kern; G Kreymann; W Krüger; P Kujath; G Marggraf; J Martin; K Mayer; A Meier-Hellmann; M Oppert; C Putensen; M Quintel; M Ragaller; R Rossaint; H Seifert; C Spies; F Stüber; N Weiler; A Weimann; K Werdan; T Welte
Journal:  Ger Med Sci       Date:  2010-06-28

7.  Continuous renal replacement therapy versus intermittent hemodialysis in intensive care patients: impact on mortality and renal recovery.

Authors:  Anne-Sophie Truche; Michael Darmon; Sébastien Bailly; Christophe Clec'h; Claire Dupuis; Benoit Misset; Elie Azoulay; Carole Schwebel; Lila Bouadma; Hatem Kallel; Christophe Adrie; Anne-Sylvie Dumenil; Laurent Argaud; Guillaume Marcotte; Samir Jamali; Philippe Zaoui; Virginie Laurent; Dany Goldgran-Toledano; Romain Sonneville; Bertrand Souweine; Jean-Francois Timsit
Journal:  Intensive Care Med       Date:  2016-06-03       Impact factor: 17.440

8.  Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012.

Authors:  R P Dellinger; Mitchell M Levy; Andrew Rhodes; Djillali Annane; Herwig Gerlach; Steven M Opal; Jonathan E Sevransky; Charles L Sprung; Ivor S Douglas; Roman Jaeschke; Tiffany M Osborn; Mark E Nunnally; Sean R Townsend; Konrad Reinhart; Ruth M Kleinpell; Derek C Angus; Clifford S Deutschman; Flavia R Machado; Gordon D Rubenfeld; Steven Webb; Richard J Beale; Jean-Louis Vincent; Rui Moreno
Journal:  Intensive Care Med       Date:  2013-01-30       Impact factor: 17.440

9.  Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008.

Authors:  R Phillip Dellinger; Mitchell M Levy; Jean M Carlet; Julian Bion; Margaret M Parker; Roman Jaeschke; Konrad Reinhart; Derek C Angus; Christian Brun-Buisson; Richard Beale; Thierry Calandra; Jean-Francois Dhainaut; Herwig Gerlach; Maurene Harvey; John J Marini; John Marshall; Marco Ranieri; Graham Ramsay; Jonathan Sevransky; B Taylor Thompson; Sean Townsend; Jeffrey S Vender; Janice L Zimmerman; Jean-Louis Vincent
Journal:  Intensive Care Med       Date:  2007-12-04       Impact factor: 17.440

10.  The hemodynamic tolerability and feasibility of sustained low efficiency dialysis in the management of critically ill patients with acute kidney injury.

Authors:  Heather E Fieghen; Jan O Friedrich; Karen E Burns; Rosane Nisenbaum; Neill K Adhikari; Michelle A Hladunewich; Stephen E Lapinsky; Robert M Richardson; Ron Wald
Journal:  BMC Nephrol       Date:  2010-11-25       Impact factor: 2.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.